From Medscape Dermatology

25th European Academy of Dermatology and Venereology (EADV) Congress

September 28 - October 02, 2016; Vienna, Austria

September 28 - October 02, 2016 Vienna, Austria

EADV Head-to-Head Results Compare Biologics for Psoriasis For patients with moderate to severe plaque psoriasis, ixekizumab is more effective than ustekinumab at 12 weeks, researchers report, but a longer-term study is needed to confirm this.
Medscape Medical News, October 5, 2016
EADV Treating Psoriasis Cuts Vascular Inflammation on FDG-PET/CT Improvements in psoriasis because of topical, biologic, and light treatment appear to reduce vascular inflammation, which in turn may reduce the risk of cardiovascular disease, researchers say.
Medscape Medical News, October 2, 2016
EADV Dupilumab Promising for Atopic Dermatitis in Phase 3 Studies The biologic significantly improved symptoms of atopic dermatitis compared with placebo. Researchers also looked at the effect of treatment on quality of life.
Medscape Medical News, October 1, 2016

Telemedicine Brings Dermatology to Underserved Populations Teledermatology dramatically increased the fraction of primary care patients who saw a dermatologist, according to a new analysis of California Medicaid claims data.
Medscape Medical News, May 5, 2016
Investigational Therapeutic Genital Herpes Vaccine Promising Phase 2 data for a novel immunotherapy for genital herpes showed a significant reduction in viral shedding and lesions, although the reduction in lesions was also seen with placebo.
Medscape Medical News, Mar 5, 2016
Psoriasis, Obesity, and Diabetes May Share Genetic Link A Danish twins study has found a strong association between psoriasis, type 2 diabetes, and obesity, with some indication there may be a modest genetic link between the three.
Medscape Medical News, May 3, 2016

Medscape Dermatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Related Resources

Previous Coverage